SDbody

SDbody is a South Korean biotechnology company specializing in the development of next-generation therapeutic antibodies using its proprietary single-domain antibody (sdAb) platform. The company focuses on VHH antibodies, also known as nanobodies, which offer advantages in stability, solubility, and the ability to reach difficult-to-access epitopes compared to traditional monoclonal antibodies. SDbody's pipeline primarily targets immuno-oncology and inflammatory diseases, leveraging multispecific formats to enhance therapeutic efficacy. By utilizing its high-throughput screening and optimization technologies, the company aims to provide innovative solutions for patients with high unmet medical needs. The platform allows for the rapid generation of high-affinity binders that can be engineered into various therapeutic formats, including bispecifics and drug conjugates.